Many antibody therapies fail to reach all cancer cells within solid tumours. Researchers have developed a spatial biology ...

Biological sex factors into cancer in ways you might not expect. In lung cancer, a form called squamous cell carcinoma ...

Cancer Support Community at Gilda’s Club is hosting an informative and supportive workshop to discuss the biology of cancer.

One of the biggest challenges in cancer research has been linking the "big picture" seen in medical scans with the ...

The collaboration addresses a key challenge in cancer research, where eligible patients miss trials due to delayed connection ...

Some breast cancer types are more likely than others to recur. Researchers have known this for more than a decade. But they have long wondered why. "How did those tumor types arise?" said Christina ...

BARCELONA, Spain--(BUSINESS WIRE)--Massive Bio, a global leader in artificial intelligence (AI) for cancer clinical trial enrollment, has announced the launch of Patient Connect, an innovative and ...

Texas-based Cizzle Bio, Inc., a biotechnology company advancing biomarker blood tests for early lung and gastric cancers, today announced the commercial launch of its proprietary CIZ1B Biomarker Blood ...

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study. Before the end of the ...

BOCA RATON, Fla.--(BUSINESS WIRE)--Massive Bio today emphasized the nationwide expansion of ACS ACTS® (Access to Clinical Trials and Support), the American Cancer Society’s program designed to help ...

Findings support the ongoing Phase 1 clinical development of BBI-940, an oral, selective kinesin degrader, as a potential first-in-class therapy for select advanced or metastatic breast cancers SAN ...

Timashev said in the note that Nuvation Bio’s safusidenib continued to be more efficacious than the only approved therapy, vorasidenib, in low-grade glioma. ・The analyst added that Nuvation Bio’s two ...